Lista de obras - Teus van Laar - Dominio Público Uruguay

A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands

artículo científico publicado en 2020

A Method for Automatic and Objective Scoring of Bradykinesia Using Orientation Sensors and Classification Algorithms.

artículo científico publicado en 2015

A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking

artículo científico publicado en 2014

A double-blind study of the efficacy of apomorphine and its assessment in 'off'-periods in Parkinson's disease

artículo científico publicado en 1993

A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease

scholarly article by Teus van Laar et al published November 1996 in Movement Disorders

A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity.

artículo científico publicado en 2016

Adaptive DBS in a Parkinson's patient with chronically implanted DBS: A proof of principle

artículo científico publicado en 2017

Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.

artículo científico publicado en 1998

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

scientific article published on 25 July 2018

Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease ⬇️

artículo científico publicado el 21 de noviembre de 1997

Attentional and perceptual impairments in Parkinson's disease with visual hallucinations

scientific article published on 13 February 2010

Characteristics of dystonia in the 18p deletion syndrome, including a new case.

artículo científico publicado en 2009

Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease

artículo científico publicado en 2020

Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapy.

artículo científico publicado en 2014

Comparison of two software programs to be used for the calculation of population pharmacokinetic parameters

artículo científico publicado en 1994

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.

artículo científico publicado en 2001

Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study

artículo científico publicado en 2017

Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.

artículo científico publicado en 2009

Deep Brain Stimulation for Essential Tremor: A Comparison of Targets.

artículo científico publicado en 2017

Deep Brain Stimulation in a Dopaminergic Non-responsive Patient With Parkinson's Disease: Case Report and Systematic Review.

artículo científico publicado en 2015

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

artículo científico publicado en 2005

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease

artículo científico publicado en 2010

Effect of Pharmacist-Led Interventions on (Non)Motor Symptoms, Medication-Related Problems, and Quality of Life in Parkinson Disease Patients: A Pilot Study

artículo científico publicado en 2018

Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease

artículo científico publicado en 2018

Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data

artículo científico publicado en 2010

Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands

artículo científico publicado en 2017

Extremely low-frequency magnetic field exposure, electrical shocks and risk of Parkinson's disease.

artículo científico publicado en 2014

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder

artículo científico publicado en 2017

Fallacious falls

artículo científico publicado en 2005

Functional (psychogenic) movement disorders associated with normal scores in psychological questionnaires: A case control study

artículo científico publicado en 2015

Graphical Tasks to Measure Upper Limb Function in Patients With Parkinson's Disease: Validity and Response to Dopaminergic Medication.

artículo científico publicado en 2015

How Many Patients would Benefit from Steering Technology for Deep Brain Stimulation?

artículo científico publicado en 2015

How typical are 'typical' tremor characteristics? Sensitivity and specificity of five tremor phenomena

artículo científico publicado en 2016

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.

artículo científico publicado en 2009

Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report.

artículo científico publicado en 2015

Intranasal apomorphine in parkinsonian on-off fluctuations

artículo científico publicado el 1 de mayo de 1992

Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.

artículo científico publicado en 1997

Lasting visual hallucinations in visual deprivation; fMRI correlates and the influence of rTMS

artículo científico publicado en 2010

Lateral and Medial Ventral Occipitotemporal Regions Interact During the Recognition of Images Revealed from Noise

artículo científico publicado en 2015

Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management.

artículo científico publicado en 2003

Managing Parkinson's disease with continuous dopaminergic stimulation.

artículo científico publicado en 2008

Mental slowness in patients with Parkinson's disease: Associations with cognitive functions?

artículo científico publicado en 2016

Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.

artículo científico publicado en 2018

Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients

artículo científico publicado en 2015

Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

artículo científico publicado en 2020

Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.

artículo científico publicado en 2006

Objective Versus Subjective Measures of Executive Functions: Predictors of Participation and Quality of Life in Parkinson Disease?

artículo científico publicado en 2017

Occupational exposure to pesticides and endotoxin and Parkinson disease in the Netherlands.

artículo científico publicado en 2014

Occupational exposure to solvents, metals and welding fumes and risk of Parkinson's disease

artículo científico publicado en 2015

Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia.

artículo científico publicado en 2018

Parkinson bradykinesia correlates with EEG background frequency and perceptual forward projection.

artículo científico publicado en 2015

Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence

artículo científico publicado en 2016

Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?

artículo científico publicado en 2015

Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.

artículo científico publicado en 1999

Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories

artículo científico publicado en 1995

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study

artículo científico publicado en 2015

Quick titration of pergolide in cotreatment with domperidone is safe and effective.

artículo científico publicado en 2001

Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism.

artículo científico publicado en 2007

Rasagiline is not for all Parkinson disease patients: the ADAGIO study

artículo científico publicado el 1 de enero de 2010

Rectal apomorphine: a new treatment modality in Parkinson's disease. ⬇️

artículo científico publicado en 1992

Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.

artículo científico publicado en 2010

Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients

artículo científico publicado en 2008

SCOPA‐cognition cutoff value for detection of Parkinson's disease dementia ⬇️

artículo científico publicado el 3 de mayo de 2011

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology

artículo científico publicado en 2020

Substituting the Target After Unsatisfactory Outcome of Deep Brain Stimulation in Advanced Parkinson's Disease: Cases From the NSTAPS Trial and Systematic Review of the Literature

artículo científico publicado en 2017

Successful treatment of intractable visual hallucinations with 5-HT 2A antagonist ketanserin

artículo científico publicado en 2018

The added value of semimicroelectrode recording in deep brain stimulation of the subthalamic nucleus for Parkinson disease.

artículo científico publicado en 2013

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.

artículo científico publicado en 2009

The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine

artículo científico publicado en 2016

The possible value of diagnosing MCI-DLB and treatment options

artículo científico publicado en 2009

The prevalence of visual hallucinations in non-affective psychosis, and the role of perception and attention

artículo científico publicado en 2016

The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel.

artículo científico publicado en 2017

The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study ⬇️

artículo científico publicado el 1 de enero de 1998

Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion.

artículo científico publicado en 2009

Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease ⬇️

artículo científico publicado el 19 de octubre de 2010

Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.

artículo científico publicado en 2015

Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy.

artículo científico publicado en 2016

Unmet needs in Parkinson's disease: New horizons in a changing landscape.

artículo científico publicado en 2016

Variability factors in the expression of stress-induced behavioural sensitisation.

artículo científico publicado en 2002

[Short-term rehabilitation of Parkinson's disease patients delays nursing home placement]

scientific article published on 01 January 2012

[Treatment of drooling in patients with parkinsonism]

scientific article published on 01 January 2010

Lista de obras de Teus van Laar

A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands

A Method for Automatic and Objective Scoring of Bradykinesia Using Orientation Sensors and Classification Algorithms.

A case-control study of the protective effect of alcohol, coffee, and cigarette consumption on Parkinson disease risk: time-since-cessation modifies the effect of tobacco smoking

A double-blind study of the efficacy of apomorphine and its assessment in 'off'-periods in Parkinson's disease

A new sublingual formulation of apomorphine in the treatment of patients with Parkinson's disease

A pharmacokinetic-pharmacodynamic model for intrathecal baclofen in patients with severe spasticity.

Adaptive DBS in a Parkinson's patient with chronically implanted DBS: A proof of principle

Antiparkinsonian drugs causing inappropriate antidiuretic hormone secretion.

Apomorphine subcutaneous infusion in patients with Parkinson's disease with persistent motor fluctuations (TOLEDO): a multicentre, double-blind, randomised, placebo-controlled trial

Assay of R-apomorphine, S-apomorphine, apocodeine, isoapocodeine and their glucuronide and sulfate conjugates in plasma and urine of patients with Parkinson's disease ⬇️

Attentional and perceptual impairments in Parkinson's disease with visual hallucinations

Characteristics of dystonia in the 18p deletion syndrome, including a new case.

Cholinergic Denervation Patterns Across Cognitive Domains in Parkinson's Disease

Clinical relevance of pharmacological and physiological data in intrathecal baclofen therapy.

Comparison of two software programs to be used for the calculation of population pharmacokinetic parameters

Consensus statement on the role of acute dopaminergic challenge in Parkinson's disease.

Continuous subcutaneous apomorphine infusion in Parkinson's disease patients with cognitive dysfunction: A retrospective long-term follow-up study

Continuous subcutaneous infusion of apomorphine can be used safely in patients with Parkinson's disease and pre-existing visual hallucinations.

Deep Brain Stimulation for Essential Tremor: A Comparison of Targets.

Deep Brain Stimulation in a Dopaminergic Non-responsive Patient With Parkinson's Disease: Case Report and Systematic Review.

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation

Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease

Effect of Pharmacist-Led Interventions on (Non)Motor Symptoms, Medication-Related Problems, and Quality of Life in Parkinson Disease Patients: A Pilot Study

Effectiveness of ReSET; a strategic executive treatment for executive dysfunctioning in patients with Parkinson's disease

Effects of cholinesterase inhibitors in Parkinson's disease dementia: a review of clinical data

Environmental exposure to pesticides and the risk of Parkinson's disease in the Netherlands

Extremely low-frequency magnetic field exposure, electrical shocks and risk of Parkinson's disease.

FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder

Fallacious falls

Functional (psychogenic) movement disorders associated with normal scores in psychological questionnaires: A case control study

Graphical Tasks to Measure Upper Limb Function in Patients With Parkinson's Disease: Validity and Response to Dopaminergic Medication.

How Many Patients would Benefit from Steering Technology for Deep Brain Stimulation?

How typical are 'typical' tremor characteristics? Sensitivity and specificity of five tremor phenomena

Impaired visual processing preceding image recognition in Parkinson's disease patients with visual hallucinations.

Improved gait performance in a patient with hereditary spastic paraplegia after a continuous intrathecal baclofen test infusion and subsequent pump implantation: a case report.

Intranasal apomorphine in parkinsonian on-off fluctuations

Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.

Lasting visual hallucinations in visual deprivation; fMRI correlates and the influence of rTMS

Lateral and Medial Ventral Occipitotemporal Regions Interact During the Recognition of Images Revealed from Noise

Levodopa-induced response fluctuations in patients with Parkinson's disease: strategies for management.

Managing Parkinson's disease with continuous dopaminergic stimulation.

Mental slowness in patients with Parkinson's disease: Associations with cognitive functions?

Monoaminergic Markers Across the Cognitive Spectrum of Lewy Body Disease.

Motor and non-motor outcomes of continuous apomorphine infusion in 125 Parkinson's disease patients

Multicenter Validation of Metabolic Abnormalities Related to PSP According to the MDS-PSP Criteria

Neuropsychological effects of bilateral STN stimulation in Parkinson disease: a controlled study.

Objective Versus Subjective Measures of Executive Functions: Predictors of Participation and Quality of Life in Parkinson Disease?

Occupational exposure to pesticides and endotoxin and Parkinson disease in the Netherlands.

Occupational exposure to solvents, metals and welding fumes and risk of Parkinson's disease

Oscillatory activity and cortical coherence of the nucleus basalis of Meynert in Parkinson's disease dementia.

Parkinson bradykinesia correlates with EEG background frequency and perceptual forward projection.

Parkinson's disease, visual hallucinations and apomorphine: A review of the available evidence

Parkinson's patients' executive profile and goals they set for improvement: Why is cognitive rehabilitation not common practice?

Pharmacokinetic-pharmacodynamic relationships of apomorphine in patients with Parkinson's disease.

Pharmacokinetics and clinical efficacy of rectal apomorphine in patients with Parkinson's disease: a study of five different suppositories

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study

Quick titration of pergolide in cotreatment with domperidone is safe and effective.

Radiotherapy to the salivary glands as treatment of sialorrhea in patients with parkinsonism.

Rasagiline is not for all Parkinson disease patients: the ADAGIO study

Rectal apomorphine: a new treatment modality in Parkinson's disease. ⬇️

Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.

Rivastigmine versus placebo in hyperhomocysteinemic Parkinson's disease dementia patients

SCOPA‐cognition cutoff value for detection of Parkinson's disease dementia ⬇️

Study protocol of the DUtch PARkinson Cohort (DUPARC): a prospective, observational study of de novo Parkinson's disease patients for the identification and validation of biomarkers for Parkinson's disease subtypes, progression and pathophysiology

Substituting the Target After Unsatisfactory Outcome of Deep Brain Stimulation in Advanced Parkinson's Disease: Cases From the NSTAPS Trial and Systematic Review of the Literature

Successful treatment of intractable visual hallucinations with 5-HT 2A antagonist ketanserin

The added value of semimicroelectrode recording in deep brain stimulation of the subthalamic nucleus for Parkinson disease.

The effects of apomorphine on visual perception in patients with Parkinson disease and visual hallucinations: a pilot study.

The need for non-oral therapy in Parkinson's disease; a potential role for apomorphine

The possible value of diagnosing MCI-DLB and treatment options

The prevalence of visual hallucinations in non-affective psychosis, and the role of perception and attention

The role and structure of the multidisciplinary team in the management of advanced Parkinson's disease with a focus on the use of levodopa-carbidopa intestinal gel.

The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study ⬇️

Tolerance to continuous intrathecal baclofen infusion can be reversed by pulsatile bolus infusion.

Transcutaneous port for continuous duodenal levodopa/carbidopa administration in Parkinson's disease ⬇️

Transcutaneous port for levodopa/carbidopa intestinal gel administration in Parkinson's disease.

Understanding the role of the Parkinson's disease nurse specialist in the delivery of apomorphine therpy.

Unmet needs in Parkinson's disease: New horizons in a changing landscape.

Variability factors in the expression of stress-induced behavioural sensitisation.